Cargando…
Expression of EZH2 in uveal melanomas patients and associations with prognosis
PURPOSE: To analyze the prognostic value and potential target for therapeutic intervention of enhancer of zeste homologue 2 (EZH2) in uveal melanomas (UM) patients. METHOD: We analyzed EZH2 expression in 89 primary UM patients by immuno- histochemistry to observe the clinicopathological and prognost...
Autores principales: | Cheng, Ying, Li, Ying, Huang, Xin, Wei, Wenbin, Qu, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652716/ https://www.ncbi.nlm.nih.gov/pubmed/29100322 http://dx.doi.org/10.18632/oncotarget.19462 |
Ejemplares similares
-
Verification of EZH2 as a druggable target in metastatic uveal melanoma
por: Jin, Bei, et al.
Publicado: (2020) -
The Tumorigenic Properties of EZH2 are Mediated by MiR-26a in Uveal Melanoma
por: Li, Yao, et al.
Publicado: (2021) -
Uveal melanoma: Estimating prognosis
por: Kaliki, Swathi, et al.
Publicado: (2015) -
Overexpression of High Mobility Group A1 Protein in Human Uveal Melanomas: Implication for Prognosis
por: Qu, Yi, et al.
Publicado: (2013) -
Changes in microRNA expression associated with metastasis and survival in patients with uveal melanoma
por: Vashishtha, Ayushi, et al.
Publicado: (2020)